Additional benefits of reduction mammaplasty: a systematic review of the literature.
Kimberly A Singh, Albert Losken
https://pubmed.ncbi.nlm.nih.gov/22090252/Actively Recruiting
Led by Cumhuriyet University Hospital · Updated on 2026-08-25
70
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to understand whether using an autologous free dermal graft during breast reduction surgery helps maintain the shape of the lower breast pole over time in women undergoing primary bilateral reduction mammaplasty. The study focuses on comparing two groups one receiving the graft support as part of their routine surgery and another undergoing the same reduction technique without the graft. The main question is whether the graft reduces lower pole lengthening between 1 and 6 months after surgery. Participants will undergo primary bilateral superior pedicle vertical scar reduction mammaplasty using standard surgical care. One group will have a de-epithelialized autologous free dermal graft placed in the lower pole region during surgery, while the other group will have the same surgery without this graft. There is no random assignment the surgical method is based on the surgeons routine practice. The study will follow participants for 6 months postoperatively. During the study, participants will attend follow-up visits at 1, 3, and 6 months after surgery. At these visits, standardized breast measurements and medical photographs will be taken, and participants will complete a breast satisfaction questionnaire at 6 months. Researchers will collect demographic, clinical, surgical, photographic, and patient-reported data to evaluate breast shape stability and satisfaction. Safety and complications will also be monitored throughout the follow-up period.
CONDITIONS
Autologous Free Dermal Graft Support in Superior Pedicle Vertical Scar Reduction Mammaplasty
M
Murat Çelik, Assistant Professor
H
Handan Derebaşınlıoğlu, Associate Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cumhuriyet University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants undergo their planned breast reduction surgery with or without the autologous free dermal graft. They attend follow-up visits at 1, 3, and 6 months after surgery for breast measurements, standardized photographs, and to complete a satisfaction questionnaire at 6 months.
3 visits (in-person at 1, 3, and 6 months post-surgery)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Kimberly A Singh, Albert Losken
https://pubmed.ncbi.nlm.nih.gov/22090252/Qun Qiao, Jiaming Sun, Cheng Liu...
https://pubmed.ncbi.nlm.nih.gov/12621182/Ozan Bitik, Hakan Uzun
https://pubmed.ncbi.nlm.nih.gov/27357632/Ryan D Wagner, Jeffrey L Lisiecki, Michael V Chiodo...
https://pubmed.ncbi.nlm.nih.gov/36061406/Donald Anthony Hudson, Sean Moodley
https://pubmed.ncbi.nlm.nih.gov/29062642/Mihye Choi, Jacob Unger, Kevin Small...
https://pubmed.ncbi.nlm.nih.gov/19387153/Cumhuriyet University Hospital
Lead Sponsor